May 4, 2008
View Full PaperTardive dyskinesia and new antipsychotics
Key Points
Key points are not available for this paper at this time.
Abstract
Purpose of reviewTo provide an update on tardive dyskinesia rates in patients treated with first-generation or second-generation antipsychotics in studies published since the last systematic review in 2004.Recent findingsAcross 12 trials (n = 28 051, age 39.7 years, 59.7% male, 70.9% white, followed